首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
【24h】

Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.

机译:氨磺必利和抗抑郁药联合治疗:老年精神病性抑郁症病例系列的临床观察。

获取原文
获取原文并翻译 | 示例
           

摘要

Psychotic depression is classified as a clinical subtype of major depressive disorder. The combination of an antidepressant with an antipsychotic agent has been demonstrated to be efficacious for the treatment of psychotic depression. However, in elderly patients with psychotic depression, little information is available on the efficacy of such combinations. Therefore, we have evaluated combination treatment for 5 weeks with amisulpride and antidepressants in non-demented elderly patients with psychotic depression. Eleven patients were treated with either citalopram 20-40 mg/day (n=5) or mirtazapine 30-60 mg/day (n=6), and amisulpride 75-100 mg/day for 5 weeks. Clinical status was evaluated at baseline and after 3 and 5 weeks using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Depression Rating Scale--17 items (HDRS) and the Clinical Global Impression Scale (CGI-S). In 5 of the 11 patients there was remission of depression, while in another 5 patients there was partial remission of depressionand in one patient there was no remission. Finally, there was resolution of psychotic symptoms in all the patients involved. One patient developed tremor and rigidity but insisted on continuing with the drug since her psychopathology has improved considerably after the addition of amisulpride to antidepressant treatment. In conclusion, some of the elderly patients with psychotic depression may benefit from the combination of amisulpride and antidepressant pharmacotherapy.
机译:精神病性抑郁症被归类为重度抑郁症的临床亚型。已经证实抗抑郁药与抗精神病药的组合对于治疗精神病性抑郁症是有效的。然而,在患有精神病性抑郁症的老年患者中,关于这种组合的功效的信息很少。因此,我们评估了非痴呆的精神病性抑郁老年患者与氨磺必利和抗抑郁药联合治疗5周的情况。 11名患者接受西酞普兰20-40 mg /天(n = 5)或米氮平30-60 mg / day(n = 6)和氨磺必利75-100 mg /天的治疗,持续5周。在基线时以及在3周和5周后,使用简短精神病学评定量表(BPRS),汉密尔顿抑郁量表--17项目(HDRS)和临床总体印象量表(CGI-S)对临床状态进行评估。 11位患者中有5位缓解了抑郁,而另外5位患者则部分缓解了抑郁,一位患者没有缓解。最后,所有相关患者的精神病症状均得到缓解。一名患者出现了震颤和僵硬,但坚持服用该药,因为在抗抑郁药中加入氨磺必利后,她的精神病理学已明显改善。总之,某些老年精神病性抑郁症患者可能会受益于氨磺必利和抗抑郁药物的联合治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号